- Home
- ESCA vs SGHT Comparison
ESCA vs SGHT Comparison
Compare ESCA & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESCA
- SGHT
- Stock Information
- Founded
- ESCA 1922
- SGHT 2011
- Country
- ESCA United States
- SGHT United States
- Employees
- ESCA N/A
- SGHT N/A
- Industry
- ESCA Recreational Games/Products/Toys
- SGHT Medical Specialities
- Sector
- ESCA Consumer Discretionary
- SGHT Health Care
- Exchange
- ESCA Nasdaq
- SGHT Nasdaq
- Market Cap
- ESCA 209.5M
- SGHT 217.7M
- IPO Year
- ESCA N/A
- SGHT 2021
- Fundamental
- Price
- ESCA $13.84
- SGHT $4.22
- Analyst Decision
- ESCA
- SGHT Buy
- Analyst Count
- ESCA 0
- SGHT 8
- Target Price
- ESCA N/A
- SGHT $4.01
- AVG Volume (30 Days)
- ESCA 19.7K
- SGHT 176.9K
- Earning Date
- ESCA 07-24-2025
- SGHT 07-31-2025
- Dividend Yield
- ESCA 4.28%
- SGHT N/A
- EPS Growth
- ESCA 9.37
- SGHT N/A
- EPS
- ESCA 0.99
- SGHT N/A
- Revenue
- ESCA $249,685,000.00
- SGHT $78,109,000.00
- Revenue This Year
- ESCA N/A
- SGHT N/A
- Revenue Next Year
- ESCA N/A
- SGHT $11.60
- P/E Ratio
- ESCA $14.36
- SGHT N/A
- Revenue Growth
- ESCA N/A
- SGHT N/A
- 52 Week Low
- ESCA $12.54
- SGHT $2.03
- 52 Week High
- ESCA $16.99
- SGHT $8.45
- Technical
- Relative Strength Index (RSI)
- ESCA 45.24
- SGHT 61.79
- Support Level
- ESCA $13.38
- SGHT $4.02
- Resistance Level
- ESCA $13.93
- SGHT $4.46
- Average True Range (ATR)
- ESCA 0.53
- SGHT 0.22
- MACD
- ESCA -0.02
- SGHT -0.03
- Stochastic Oscillator
- ESCA 33.64
- SGHT 71.43
About ESCA Escalade Incorporated
Escalade Inc manufactures and distributes sporting goods for a varied range of activities. These sports include archery, table tennis, basketball goals, trampoline, play systems, fitness, game tables like hockey and soccer, billiards, darting, and other outdoor games. These products are sold under the brand names like Goalrilla, Goalsetter, Woodplay, Silverback, Nodor, Rage, Child Life, among others. The geographic segments in which the company operates are North America, Europe and others out of which a substantial part of the revenue is generated from North America region.
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.